DAMARTEX (ALDAR.PA) Fundamental Analysis & Valuation

EPA:ALDAR • FR0000185423

Current stock price

2.3 EUR
+0.04 (+1.77%)
Last:

This ALDAR.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALDAR.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALDAR has reported negative net income.
  • ALDAR had a positive operating cash flow in the past year.
  • ALDAR had negative earnings in 4 of the past 5 years.
  • ALDAR had a positive operating cash flow in 4 of the past 5 years.
ALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With a Return On Assets value of -4.17%, ALDAR is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
  • ALDAR's Return On Equity of -24.97% is on the low side compared to the rest of the industry. ALDAR is outperformed by 84.78% of its industry peers.
Industry RankSector Rank
ROA -4.17%
ROE -24.97%
ROIC N/A
ROA(3y)-6.1%
ROA(5y)-3.23%
ROE(3y)-30.63%
ROE(5y)-17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ALDAR.PA Yearly ROA, ROE, ROICALDAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • Looking at the Gross Margin, with a value of 64.90%, ALDAR is in line with its industry, outperforming 54.35% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALDAR has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for ALDAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.01%
ALDAR.PA Yearly Profit, Operating, Gross MarginsALDAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. ALDAR.PA Health Analysis

2.1 Basic Checks

  • ALDAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALDAR has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALDAR has more shares outstanding
  • ALDAR has a worse debt/assets ratio than last year.
ALDAR.PA Yearly Shares OutstandingALDAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ALDAR.PA Yearly Total Debt VS Total AssetsALDAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • ALDAR has an Altman-Z score of 1.08. This is a bad value and indicates that ALDAR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.08, ALDAR is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ALDAR is 10.83, which is on the high side as it means it would take ALDAR, 10.83 years of fcf income to pay off all of its debts.
  • ALDAR's Debt to FCF ratio of 10.83 is on the low side compared to the rest of the industry. ALDAR is outperformed by 60.87% of its industry peers.
  • ALDAR has a Debt/Equity ratio of 2.67. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 2.67, ALDAR is doing worse than 89.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 10.83
Altman-Z 1.08
ROIC/WACCN/A
WACC4.72%
ALDAR.PA Yearly LT Debt VS Equity VS FCFALDAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • ALDAR has a Current Ratio of 1.10. This is a normal value and indicates that ALDAR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.10, ALDAR is doing worse than 84.78% of the companies in the same industry.
  • A Quick Ratio of 0.48 indicates that ALDAR may have some problems paying its short term obligations.
  • The Quick ratio of ALDAR (0.48) is worse than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.48
ALDAR.PA Yearly Current Assets VS Current LiabilitesALDAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. ALDAR.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 49.84% over the past year.
  • Looking at the last year, ALDAR shows a decrease in Revenue. The Revenue has decreased by -1.00% in the last year.
  • The Revenue has been decreasing by -5.35% on average over the past years.
EPS 1Y (TTM)49.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.14%
Revenue 1Y (TTM)-1%
Revenue growth 3Y-10.17%
Revenue growth 5Y-5.35%
Sales Q2Q%0.17%

3.2 Future

  • Based on estimates for the next years, ALDAR will show a very strong growth in Earnings Per Share. The EPS will grow by 444.33% on average per year.
  • Based on estimates for the next years, ALDAR will show a very negative growth in Revenue. The Revenue will decrease by -16.58% on average per year.
EPS Next Y-1433.33%
EPS Next 2Y444.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-16.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALDAR.PA Yearly Revenue VS EstimatesALDAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 200M 400M 600M
ALDAR.PA Yearly EPS VS EstimatesALDAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

3

4. ALDAR.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALDAR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALDAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDAR.PA Price Earnings VS Forward Price EarningsALDAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • ALDAR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALDAR is cheaper than 69.57% of the companies in the same industry.
  • ALDAR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALDAR is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.34
EV/EBITDA 7.29
ALDAR.PA Per share dataALDAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALDAR's earnings are expected to grow with 444.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y444.33%
EPS Next 3YN/A

0

5. ALDAR.PA Dividend Analysis

5.1 Amount

  • No dividends for ALDAR!.
Industry RankSector Rank
Dividend Yield 0%

ALDAR.PA Fundamentals: All Metrics, Ratios and Statistics

DAMARTEX

EPA:ALDAR (3/17/2026, 7:00:00 PM)

2.3

+0.04 (+1.77%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-09
Earnings (Next)N/A
Inst Owners4.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.68M
Revenue(TTM)521.23M
Net Income(TTM)-17.60M
Analysts40
Price Target4.59 (99.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-217.65%
EPS NY rev (3m)-217.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.34
P/OCF 0.87
P/B 0.38
P/tB N/A
EV/EBITDA 7.29
EPS(TTM)-1.56
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)1.71
FCFY74.4%
OCF(TTM)2.64
OCFY114.84%
SpS44.93
BVpS6.08
TBVpS-4.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -24.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.9%
FCFM 3.81%
ROA(3y)-6.1%
ROA(5y)-3.23%
ROE(3y)-30.63%
ROE(5y)-17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.01%
F-Score7
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 10.83
Debt/EBITDA 6.19
Cap/Depr 33.26%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion 100.58%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.48
Altman-Z 1.08
F-Score7
WACC4.72%
ROIC/WACCN/A
Cap/Depr(3y)28.96%
Cap/Depr(5y)40.82%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.14%
EPS Next Y-1433.33%
EPS Next 2Y444.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1%
Revenue growth 3Y-10.17%
Revenue growth 5Y-5.35%
Sales Q2Q%0.17%
Revenue Next YearN/A
Revenue Next 2Y-16.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y92.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.55%
FCF growth 3YN/A
FCF growth 5Y1.01%
OCF growth 1Y-7.66%
OCF growth 3YN/A
OCF growth 5Y-0.56%

DAMARTEX / ALDAR.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DAMARTEX (ALDAR.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALDAR.PA.


What is the valuation status of DAMARTEX (ALDAR.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to DAMARTEX (ALDAR.PA). This can be considered as Overvalued.


How profitable is DAMARTEX (ALDAR.PA) stock?

DAMARTEX (ALDAR.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for DAMARTEX?

The Earnings per Share (EPS) of DAMARTEX (ALDAR.PA) is expected to decline by -1433.33% in the next year.